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Resumo 
 
Os recentes avanços na tecnologia e poder computacional e o cada vez mais 
frequente uso de registos de saúde eletrónicos abriram as portas a novas pesquisas que 
exploram a informação destes registos para melhorar os cuidados médicos, 
nomeadamente nos diagnósticos e nas prescrições terapêuticas. 
Uma das maiores preocupações em termos de saúdes pública é a resistência a 
antibióticos. Este fenómeno ocorre quando algumas das subpopulações de um 
microrganismo sobrevivem após serem expostas a antibióticos, tornando-se mais 
difíceis de controlar. É, portanto, essencial utilizar antibióticos de uma forma mais 
eficaz. A Organização Mundial de Saúde já declarou publicamente que, a não ser que se 
consiga reduzir o rápido crescimento da resistência a antibióticos a que tem assistido, 
estamos a caminhar para uma era pós-antibióticos, onde a taxa de mortalidade por 
infeções comuns vai disparar devido à falha expectável de tratamentos médicos 
habituais. 
Hoje em dia, o antibiótico mais adequado apenas pode ser descoberto após os 
resultados dos testes dos laboratórios de análise serem conhecidos, então a maioria dos 
médicos fazem prescrições com base na sua experiência. No entanto, ao analisar um 
grande volume de dados clínicos, é possível que o pessoal clínico descubra informações 
mais relevantes que podem ajudá-los nas suas decisões. A equipe médica deve ter mais 
informações aquando da tomada de decisões. 
A análise computacional dos registos de saúde electrónicos representa uma 
oportunidade para combater a tendência crescente de resistência aos antibióticos, pois a 
nova informação descoberta pode auxiliar os médicos na tomada de melhores 
diagnósticos e prescrições. Isso poderia aumentar a qualidade da assistência médica, 
reduzindo não só a mortalidade e morbidade, mas também os custos. 
O objetivo deste projeto foi investigar se era possível desenvolver modelos de 
aprendizagem supervisionadas que fossem capazes de classificar os pacientes consoante 
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o risco de resistência a antibióticos utilizando as informações que são geralmente 
recolhidas a nível clínico e laboratorial em termos de resistência aos antibióticos. O 
conjunto de dados que apoiaram este projecto foi gentilmente partilhado através de uma 
colaboração com o Laboratório de BIOFIG na FCUL, e representa dados reportados por 
vários hospitais portugueses em matéria de resistência aos antibióticos durante um 
período de 11 anos. 
Duas tarefas foram realizadas para cumprir os objectivos: pré-processamento dos 
dados e aprendizagem supervisionada. No pré-processamento dos dados foram usadas 
técnicas de limpeza, de estandardização e de transformação de dados, de modo a tornar 
os dados o mais consistente possível para que pudessem depois seguir para a 
aprendizagem supervisionada. Aqui foram aplicados métodos de aprendizagem 
automática sobre os dados para treinar um modelo capaz de prever a resistência aos 
antibióticos ao nível do paciente, com base em parâmetros demográficos, clínicos e 
laboratoriais. 
Numa primeira fase, a classificação de cada paciente como resistente ou não 
resistente a cada antibiótico foi realizada individualmente. Nela foram testados diversos 
algoritmos, como Decision Tables (DT), Random Forests (RF), Multilayer Perceptron 
(MP) e Support Vector Machines (SVM), sempre com validação cruzada com 10 
subconjuntos. Foram ainda feitos testes com os filtros SMOTE a 200% e 500% e Spread 
Subsample com um rácio 1:1. 
Os resultados não foram satisfatórios, portanto os testes foram repetidos após se 
fazer uma avaliação sobre ganho de informação dos atributos, de modo se testar apenas 
sobre os atributos mais relevantes. No entanto, os resultados pouco melhoraram. 
Foi então compreendido que a formulação inicial do problema (uma classe para 
cada antibiótico) era provavelmente inadequada. Assim sendo, problema de 
classificação foi reformulado, desta feita seguindo para uma abordagem de classificação 
por perfil de resistência dos pacientes. Técnicas de agrupamento foram aplicadas sobre 
os dados para identificar perfis de resistência, ou seja, pacientes que apresentaram 
resistência ao mesmo conjunto de antibióticos. 
Após isso, uma estratégia de classificação de dois níveis foi concebida de forma a 
classificar os pacientes de acordo com o seu perfil de resistência.  
Para o primeira nível, a classificação filtrada, uma estratégia de classificação duas 
classes foi utilizada, em que todas as instâncias pertencentes a grupos de perfis 
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resistentes foram agrupados numa única classe, enquanto que os restantes doentes sem 
qualquer resistência foram agrupados noutra classe distinta. A classificação filtrada foi 
sempre realizada com um filtro SMOTE com a percentagem a 500% e os algoritmos de 
classificação foram testados Decision Tables e Random Forests, com uma validação 
cruzada com 10 subconjuntos. 
Seguidamente, no segundo nível, as instâncias que foram classificadas como 
resistentes foram novamente separadas consoante os resultados da técnica de 
agrupamento anteriormente utilizada, classificadas via classificação multi-classe, para 
que o conjunto de dados multi-classe pudesse ser tratado por classificadores de 2 
classes. Os algoritmos de classificação utilizados foram os mesmos que para o primeiro 
nível, apenas sem filtro, e os métodos utilizados para transformar o problema multi-
classe em vários de 2 classes foram 1-contra-todos e 1-contra-1. 
Notou-se uma melhoria geral nos resultados, mas ainda com um desempenho 
bastante reduzido na maioria dos perfis. Outras duas abordagens foram feitas usando 
esta estratégia de classificação de dois níveis. Uma baseada numa classificação direta de 
instâncias em perfis de resistência, corrigindo algumas das atribuições erradas dos 
agrupamentos feitas pelo algoritmo de agrupamento, tendo as instâncias que foram 
erradamente colocadas num agrupamento sido realocadas. A outra, para além do 
reajustamento que acabou de ser explicado, continha ainda o número de instâncias 
pertencentes a cada agrupamento por mês. Novamente, apesar de terem sido notadas 
melhoras gerais, não eram suficientemente satisfatórias. Foram ainda realizadas 
previsões futuras sobre a evolução futura do número de pacientes resistentes por perfil 
de resistência recorrendo a séries temporais. 
Apesar dos resultados da classificação por perfil de resistência terem um baixo 
desempenho no geral, tiveram algum sucesso com o perfil onde os pacientes eram 
resistentes a Tetramicina e Cloranfenicol. Dadas as várias falhas detectadas a nível da 
qualidade dos dados (dados em falta, heterogeneidade de nomeações e categorias, 
número reduzido de pacientes resistentes para alguns antibióticos) é expectável que o 
desempenho para outros perfis possa aumentar, utilizando um conjunto de dados com 
maior qualidade e representatividade.  
Este projecto realçou dois aspectos importantes: a qualidade e representatividade 
dos dados recolhidos, pois após terem sido testadas várias abordagens diferentes e os 
resultados correspondentes analisados, foi determinado que a informação reportada não 
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tinha a capacidade preditiva apropriada, pelo que não foi possível desenvolver o modelo 
anteriormente descrito; e a compreensão dos dados e do seu domínio, verificado quando 
se demonstrou que a classificação por perfil de resistência obteve melhores resultados 
que a classificação por antibiótico.  
Uma vez que os dados recolhidos cobrem um período de até há 10 anos, é 
expectável que com as recentes evoluções nos sistemas de informação de saúde 
empregues por hospitais portugueses, uma recolha de dados mais recentes iria fornecer 
dados de melhor qualidade. Seria assim interessante aplicar a estratégia proposta sobre 
dados mais recentes, e testar estes iriam de facto melhorar o desempenho da 
classificação. 
 
Palavras-chave: Aprendizagem supervisionada, aprendizagem automática sobre dados 
clínicos, previsão de resistência a antibióticos, prospeção de dados, registos de saúde 
eletrónicos 
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Abstract 
 
The recent advances in technology and computation power and the expanding use 
of electronic health records have opened new avenues of research that explore the 
information in these records to improve healthcare, namely in diagnosis and therapeutic 
prescriptions. One increasingly relevant public health concern is antibiotic resistance. 
The World Health Organization has already stated that unless the antibiotic resistance's 
growing trend is reduced, we are heading towards a post-antibiotic era, where the death 
rate of common infection will rise due to the expected failure of standard medical 
treatments. 
The ability to successfully predict antibiotic resistance risk can have a significant 
impact worldwide, because it can help clinicians in selecting appropriate antibiotics. 
This can help reduce antibiotic resistance levels, improve patient treatment, and 
ultimately decrease healthcare costs. 
This project's goal is to investigate if it is possible to develop supervised learning 
models that are able to classify patients regarding their antibiotic resistance risk using 
the information that has been usually collected at a clinical and laboratorial level and 
reported by Portuguese hospitals. This was accomplished by taking electronic health 
records data, pre-processing it using data cleaning, standardization and transformation 
techniques, and then applying machine learning methods to it to train a model capable 
of predicting antibiotic resistance at the patient level. 
The most successful classification strategy was based on a two-stage multi-class 
approach, where patients were classified into resistance profiles previously obtained 
using clustering techniques. Nevertheless, performance was still very low for most 
resistance profiles, no doubt influenced by the several issues in data quality detected. 
An improved collection of data, with fewer errors and other variables reported would 
likely have a great impact in performance.  
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Keywords: Supervised learning, machine learning on clinical data, antibiotic resistance 
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Chapter 1 
Introduction 
This dissertation is focused on predicting antibiotic resistance risk for patients 
using supervised learning approaches over demographic, clinical and laboratory data. 
The first chapter will present my motivation, objectives and contributions, as well as the 
document structure. 
 
1.1  Motivation 
Antibiotic resistance is one of the public healthcare’s main concerns, mainly for 
driving up healthcare costs, increasing the severity of disease, and increasing the death 
rates of some infections [1-3]. The WHO’s (World Health Organization) 2014 report on 
global surveillance of antimicrobial resistance [4] shows that antibiotic resistance is an 
actual problem at a global scale, putting at risk the ability to treat common infections in 
the community and hospitals. 
Nowadays, the most appropriate antibiotic can only be found after the lab analysis 
test results are known, so most of the doctors make prescriptions based on their 
experience alone. It is vital to use antibiotics in a more effective way and to reduce the 
antibiotics resistance growing trend, or else we are headed towards a post-antibiotic era, 
in which common infections and minor injuries can once again kill. 
The recent advances in technology and computation power, combined with the 
expanding use of electronic health records, represent an opportunity to fight the rising 
antibiotic resistance trend by aiding clinicians in making better diagnostics and 
therapeutic prescriptions [5]. By analyzing a large volume of clinical data, it is possible 
to give clinical staff more relevant information that can help them on their decisions. 
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This could potentially increase the quality of healthcare, reducing mortality and 
morbidity, while also reducing costs. 
 
1.2  Objectives 
This dissertation's goal was to investigate if it was possible to develop supervised 
learning models that were able to classify patients regarding their antibiotic resistance 
risk using the information that is usually collected at a clinical and laboratorial level in 
terms of antibiotic resistance by Portuguese hospitals. The dataset that supported this 
project has been kindly shared through a collaboration with the BIOFIG Lab at FCUL, 
and represents data reported by several Portuguese hospitals concerning antibiotic 
resistance over an 11 year period. 
Two tasks were planned to accomplish the goal: 
 
1. Data pre-processing: (1) Data cleaning for handling missing and 
corrupted values; (2) Data transformation for improved grouping of some data, such as 
age and antibiotic type; (3) Data standardization for solving the heterogeneities in 
names and scales. 
 
2. Supervised learning: Application of machine learning methods to the data 
to train a model capable of predicting antibiotic resistance at the patient level, based on 
demographical, clinical and laboratory parameters. 
 
 
1.3  Contributions 
The contributions of this project include: 
 
 The identification and solution of the data quality issues: Several problems 
were detected including a large portion of missing values, lack of 
standardized nomenclature and the usage of different scales or categories. 
The magnitude of these issues demonstrates that there is a need to revise 
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the EHR data collection procedure that was employed to generate the 
dataset.  
 
 The creation of patient resistance profiles by clustering of individual 
antibiotic resistance status for each patient: These profiles allow for a 
better understanding of the domain, and highlight the complexity of the 
antibiotic resistance phenomenon. 
 
 The development of a two-stage multi-class classification strategy to 
classify patients according to their antibiotic resistance profile: Although 
performance was very low for most of the profiles, the promising values 
achieved in predicting one of the profiles support further investment in this 
strategy using datasets with improved quality and representativity. 
 
 This project was featured on the 4th Bioinformatics Open Days 2015 held 
in the Faculty of Sciences of the University of Lisbon on April 2015 in the 
form of a poster presentation [6]. 
 
1.4  Document structure 
The document is organized in the following way: 
 
 Chapter 2 - State of the Art: Describes some basic concepts useful for a 
good understanding of the project and presents some of the most of the 
most relevant work in the area. 
 Chapter 3 - Methods: Presents the dataset and describes the methods and 
strategies employed along the project. 
 Chapter 4 - Results: Presents a statistical analysis of the dataset, as well as 
the results of the classification tests described in the previous section. 
 Chapter 5 - Discussion: Presents a critical discussion of the developed 
work, debating the fulfilment of the objective and the additional 
contributions. 
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 Chapter 6 - Conclusions: This section summarizes the main conclusions of 
this work and discusses possible avenues for future work. 
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Chapter 2 
State of the Art 
In this chapter some basic concepts that are crucial for a good understanding of 
this dissertation will be presented, including electronic health records, data mining, 
machine learning and time series analysis. This section is followed by relevant related 
work. Although supervised learning over electronic health records has been used in 
several clinical domains, such as oncology diagnosis [7], this review will only focus on 
antibiotic resistance prediction. 
 
2.1  Basic concepts 
Electronic health records (EHR) store and integrate important data, including 
demographic patient information, drug prescription data or medical notes describing 
medical reasoning behind the prescription, over time. Thanks to its administrative data, 
EHR is widely used in population-based health research [8]. When dealing with a 
certain case, doctors can study what were their peers' opinions at the time and how they 
affected their patients' health just by looking at data stored from previous similar cases. 
Furthermore, it gives doctors the ability to predict how the patient's condition will 
evolve, allowing them to intervene earlier [5, 9]. 
Data cleaning (also called data cleansing) consists of exploring the data for 
possible problems and making an effort to correct errors, by detecting and 
deleting/correcting erroneous or irrelevant records from a dataset. The quality of data 
used for data mining or machine learning can have a considerable impact on the 
performance of these strategies. There are several problems that can be found in 
electronic health records data, from missing, ambiguous or incorrect values to 
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misspelling errors. Therefore, data cleaning frequently involves human judgment to 
decide which points are valid and which are not [10]. 
The term dataset usually refers to data selected and arranged in rows and columns, 
all related but separate elements, ready to be processed and manipulated as a whole by a 
computer. The values in a dataset may be of any of the kinds described as a level of 
measurement, usually numbers or nominal data. 
Data Mining techniques can be applied to EHR to discover novel insights about 
diseases, such as co-morbidities, patient susceptibilities, etc. Data Mining deals with 
large amounts of data in order to discover useful patterns or relationships unknown until 
the time, and is more successful if there is much data available. By making use of these 
large clinical data collections, it is possible to make a retrospective analysis, which 
brings forth an opportunity to deepen our knowledge regarding clinical processes [11, 
12]. One data mining technique employed to support future predictions is time series 
analysis. Time series are a set of repeated observations of the same variable for 
statistical analysis, pattern recognition or forecasting, among other areas [13]. 
Machine learning algorithms provide computers with the ability to learn from data 
automatically without human intervention. It plays a vital role in bioinformatics and 
medical diagnosis nowadays [14, 15]. It is a class of algorithms that are data-driven, i.e. 
it is the data that dictates the best answer. Machine learning focuses on the development 
of computer programs that can teach themselves to grow and change when exposed to 
new data and deals with the construction and study of algorithms that can learn from 
that same data. The machine learning task inferring a function from labelled data is 
called supervised learning. 
Machine learning is often confused with data mining, due to their significant 
overlap. But while machine learning acts based on the known properties from the 
training data, data mining is more focused on knowledge discovery (the discovery of 
previously unknown properties in the data). By applying machine learning techniques to 
the data stored in electronic medical records and electronic health records it is possible 
to aid diagnosis and improve therapeutic choice [5]. 
One kind of machine learning algorithms called supervised learning, rely on using 
example inputs and their desired outputs, so that the algorithm can generate a model that 
maps inputs to outputs. This usually means that a set of instances is classified into one 
of two classes according to a model learned from a number of labelled examples.  
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When datasets have more than two classes, multiclass classification is applied, 
which is the problem of constructing a function which, knowing that each training point 
belongs to one of several different classes, given a new data point, will correctly predict 
the class to which the new point belongs [16]. 
When examples are not labelled, we have unsupervised learning instead. A 
commonly used unsupervised learning technique is clustering. Jain et al. [17] define 
clustering as the unsupervised classification of patterns into groups of similar objects. 
Those groups are named clusters. Clustering is useful in several situations, such as 
pattern classification, like classifying pathologies by their features. 
To improve the quality of machine learning strategies it is common to employ 
feature selection, the process of selecting a subset of relevant features from the data for 
application of a learning algorithm. When using a feature selection technique, it is 
assumed that the data contains irrelevant facts. The best subset contains the least 
number of dimensions that most contribute to accuracy, discarding those that are 
irrelevant. There are several feature selection techniques. One of them, related to the so-
called filter approach, assumes evaluation of individual features or feature subsets 
independently from the learning algorithm. The wrapper approach is another technique, 
which assumes evaluation of feature subsets according to the accuracy of predictive 
model built on these feature subsets [2]. 
 
2.2  Related work 
The key to controlling the spread of antibiotic resistance is using antibiotics in a 
smart, thoughtful way. And to do so, being able to predict a bacteria’s resistance to a 
given antibiotic is fundamental. Hence the extreme importance of applying data mining 
techniques and machine learning methods to clinical data. Several approaches have been 
used so far to tackle this issue. One is to take clinical data with record of ill patients and 
their medication, analyze their evolution, and, by crossing data to find similar cases, 
define what would be the best course of treatment and predict what should happen. 
Pechenizkiy et al. [2] followed this approach when in 2005 they applied various 
data mining techniques to hospital data from patients who had meningitis for the sake of 
predicting antibiotic resistance for nosocomial infections. Naive Bayes, Bayesian 
Network, C4.5 decision trees, k-nearest (1, 3 and 15) neighbours and JRip were applied 
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as basic classifiers. The nearest neighbour-based (especially 1NN and 15NN) and the 
decision tree classifiers achieved the best accuracy results, all of them over 78%. On the 
other hand, the Bayesian features performed poorly. This may be due to the redundancy 
and high correlation of the features, seeing as they were all used. 
However, when feature selection was applied the results differed and more 
relevant conclusions could be made. The filter approach usage taught them that most 
information was concentrated in the features related to antibiotics themselves, while the 
wrapper approach showed that the multidimensionality of the original space had a 
negative effect. Furthermore, by applying a regular manual feature selection they 
discovered that groupings of antibiotics and pathogens into categories were appropriate 
and the grouping features contained relevant information and that their data contained 
some interesting patterns independent from antibiotics and pathogens related to the 
demographics and hospital stay information only. It was safe to make these assumptions 
because, although the accuracy results were lower than when they had tested without 
feature selection, they were still much higher than 50%. 
When natural clustering (strategy of grouping objects into groups of similar 
objects) was applied and the base classifiers were applied on the antibiotic group, who 
had three subgroups, it was not only observed that for two of them the cluster classifiers 
outperformed the global classifiers for every type of base classifiers, but also that their 
average accuracy is higher when they are applied locally within each cluster comparing 
to the global classifiers' accuracy. 
Also in 2005, Tsymbal et al. [18] proposed the use of an ensemble integration 
technique that would help to better handle concept drift at an instance level. Three data 
sets were used, two of which were synthetically generated, the other being a real-world 
data set from the domain of antibiotic resistance in nosocomial infections. This real-
world data set had already been used in paper [2]. In machine learning, concept drift is 
the name given to the problem caused by the unforeseen changes over time of the data 
distributions. This complicates the task of learning a model from data because the 
predictions become less accurate as time passes. These changes may cause a change in 
the data distribution as well, which may lead to the necessity of revising the current 
model, as the model’s error may no longer be acceptable with the new data distribution 
[1]. Several learning algorithms were tried, such as Naive Bayes, decision trees (C4.5) 
or k-nearest neighbours, and five integration techniques were considered: voting (V), 
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weighted voting (WV), dynamic selection (DS), dynamic voting (DV) and dynamic 
voting with selection (DVS). While DS simply selects a classifier with the best local 
predictive performance, in DV, each base classifier receives a weight that is 
proportional to its estimated local performance, and the final classification is produced 
using weighted voting. In DVS, the base classifiers with the worst local performances 
are discarded and locally weighted voting (DV) is applied to the remaining classifiers. 
Their experiments showed that, in k-NN, dynamic integration was not very 
sensitive to the size of the neighbourhood. Besides, they proved that dynamic selection 
(DS) often had the best performance in the present context, although only when the 
validation set was representative enough in order to reliably predict local performance. 
It was concluded that dynamic integration often results in better accuracy with the 
considered datasets that the more commonly used weighted voting, which proves that it 
can be an appropriated integration technique for handling concept drift. 
Another possible approach is to work with clinical data that doesn't contemplate 
patient data at all. Instead of analyzing similar past cases to know what to expect and 
how to act, it focus solely on applying antibiotics to pathogens and study their resistance 
over time. 
Teodoro et al. [3] chose to follow this approach on their recent work where a 
machine learning method that can forecast antibiotic resistance trends based on the k-
nearest embedding vectors was developed. Their dataset contained several time series of 
four pathogens tested against a set of antibiotics over a decade and their approach 
combined robust trend extraction and prediction methods that did not make any a priori 
assumptions of the underlying bacterial and antibiotic resistance dynamics. 
They concluded that the models that employed decomposition of the time series 
and filtered out noisy components improved significantly the forecasting accuracy over 
the other models, and that as the time horizon increases, the power of the models that 
use decomposition becomes more evident. 
Both Pechenizkiy et al. [2] and Tsymbal et al. [18] use WEKA, a workbench for 
machine learning that aids in the application of machine learning techniques to a variety 
of real-world problems [19]. It contains tools for data pre-processing, classification, 
regression, clustering, association rules and visualization. WEKA is widely used in 
many diverse areas of bioinformatics, such as predicting breast cancer survivability or 
forecasting antibiotic resistance trends. It is mainly used for data classification, event 
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prediction and developing new machine learning skills. WEKA is developed by the 
University of Waikato [20].  
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Chapter 3 
Methods 
This chapter presents the dataset used in this work, and all the methods and 
strategies employed. 
 
3.1  Data Characterization 
The dataset used in this project was collected from electronic health records for 
the purpose of reporting antibiotic resistance. It does not represent the full EHR for each 
patient, but the data thought necessary to report. It was collected from 33 different 
Portuguese hospitals between 1993 and 2005, yielding a total of 5118 entries. The data 
was made available in spreadsheet files. These are its main features, including a 
description and examples of values in Table 3.1.1: 
 
 Whether the patient was an in-patient or if he was only attending a doctor's 
appointment 
 Name of the laboratory where the analysis was made 
 Date of the analysis 
 Origin of the test fluid 
 Category of the type of infection 
 Serotype 
 Patient age 
 Patient gender 
 Patient's first diagnosis 
 Antibiotics test results 
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Feature name Description Example of Values 
Hos/Comu 
Whether the patient was an in-
patient or if he was only attending a 
doctor's appointment 
"Hospital" or 
"Community" 
Lab 
Name of the laboratory where the 
analysis was made 
"HCascais", "HSM", 
"HPV" 
Date Date of the analysis 
"31/05/1995", 
"16/06/1995", 
"26/06/1995" 
Product Origin of the test fluid "Nasal", "Liq." 
Product Category Category of the type of infection 
Lower respiratory tract 
("Respiratória Inferior"), 
Upper respiratory tract 
("Respiratória Superior") 
Serotype Serotype "23F", "14", "9V" 
Age Patient age "1", "68" 
Gender Patient gender "M" or "F" 
Diagnosis Patient's first diagnosis "Pneumonia", "HIV+" 
Resistance results 
Antibiotics test results where the 
resistance level (sensitive, 
intermediate or resistant) was 
indicated by the colour of the value 
"0.0125" (blue), "0.5" 
(orange), "3.2" (red) 
 
Table 3.1.1: Main features of the dataset 
 
 
Each patient was tested for 10 different antibiotics: Penicillin, Tetramycin, 
Erythromycin, Clindamycin, Chloramphenicol, Ofloxacin, Cefotaxime, Ceftriaxone, 
SXT and OXA. 
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3.2  Data Cleaning and Normalization 
Several entries did not have resistance values for any of the antibiotics, and were 
therefore removed. From the original 5118 entries, 3813 remained after this step. 
Although several of the remaining entries had missing values, such as the patient's age 
or gender, or the origin of the test fluid, they were kept because the loss of vital 
information was minimal. 
Some data features were also normalized. It was noticed that the data contained 
heterogeneous labels due to lack of coherence since it was collected by different staff 
(i.e., different ways to write the patient's age or the hospital name). Consequently, there 
was a need to check every different notation that referred to the same thing and change 
these entries so that they matched. 
Furthermore, since the frontier values for the antibiotic resistance categories 
(resistant, intermediate or sensitive) vary from each antibiotic and the only way to know 
in which category a patient fit in was by checking the color that was given to its 
antibiotic resistance value, there was a need to create a new feature for each antibiotic  
that indicated if a patient showed resistance. 
 
3.3  Data Transformation 
All hospitals were labelled according to their NUTS II region (see Figure 3.3.1). 
Test fluids were grouped into probable infection types, according to expert validation. 
The patient's age were transformed into different age categories, e.g. 5 year slots, 
children vs. adults. 
These transformed entries were added to the dataset as new features due to their 
probable relevance for the classification. 
Besides these transformations, the antibiotics were also grouped by similarity in 
antibiotic families. These were the aggregations made: 
 
 OXA and Penicillin 
 Erythromycin and Clindamycin 
 Cefotaxime and Ceftriaxone 
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Figure 3.3.1: NUTS II Regions of Portugal 
 
 
It was established that if a patient showed resistance to any of the antibiotics of 
the family then the patient would be resistant to the family. By having the antibiotics 
grouped by families, new possibilities of finding interesting patterns may arouse. 
 
3.4  Classification by Antibiotic 
In a first step, classification of each patient as resistant or susceptible to each 
antibiotic individually was performed. Each patient was taken as an instance, described 
with the following attributes: 
 
 Whether the patient was an in-patient or if he was only attending a doctor's 
appointment 
 Region of the laboratory where the analysis was made 
 Date of the analysis 
 Origin of the test fluid 
 Category of the type of infection 
 Serotype 
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 Patient age 
 Patient gender 
 Antibiotics test results 
 
WEKA 3.7.12 [20] was employed, due to its widespread use and its simplicity. 
In a first approach, it was decided to apply the Decision Tables (DT), Random 
Forests (RF), Multilayer Perceptron (MP) and Support Vector Machines (SVM) [21] 
algorithms, in a 10-fold cross validation. These algorithms represent a selection based 
on simplicity and readability of results (DT, RF) and performance reported in other 
biomedical informatics tasks (SVM, MP). 
A Decision Table is a tabular form for displaying decision logic [22]. Random 
Forest is an ensemble of unpruned classification or regression trees created by using 
bootstrap samples of the training data and random feature selection in tree induction 
where prediction is made by aggregating the predictions of the ensemble [23]. The 
Multilayer Perceptron consists of a system of simple interconnected neurons, or nodes, 
which is a model representing a nonlinear mapping between an input vector and an 
output vector [24]. A Support Vector Machine is an algorithm that learns by example to 
assign labels to objects [25]. The parameters used in each algorithm can be consulted in 
Appendix I. 
Since class imbalance was detected, the SMOTE [26] and Spread Subsample [27] 
filters were also tested. The SMOTE filter consists on over-sampling the minority class 
by creating similar (not equal) instances. Using a SMOTE filter with a percentage of 
200% means that the amount of new SMOTE instances to be created is twice the 
number of instances of the minority class. On the other hand, the Spread Subsample 
filter produces a random subsample of the dataset, where the ratio between the 
frequency of classes can be defined. 
Afterwards, an Information Gain Attribute Evaluation was performed, in order to 
test classification using only the most relevant features. The algorithms and filters used 
for this test were the same as before. 
Finally, similar tests were made for the antibiotic families mentioned in section 
3.3, using all relevant features and Decision Tables without any filter applied and with 
the same filters previously used (SMOTE and Spread Subsample, both with the same 
settings as before). 
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3.5  Antibiotic Resistance Profiling 
The next approach was to test classification by resistance profile. Clustering 
techniques were applied to identify resistance profiles, i.e. patients that showed 
resistance to the same set of antibiotics. 
By making use of WEKA once again, an expectation-maximization algorithm was 
used over the patient instances whose features consisted only on antibiotic resistance 
values in order to assign a probability distribution to each instance which indicates the 
probability of it belonging to each of the clusters. The number of clusters was selected 
automatically by cross-validation. Each resulting cluster represented a different 
resistance profile. 
 
3.6  Classification by Resistance Profile 
The classes for each instance were then altered to one of the identified resistance 
profiles. An ID was also added for instance identification purposes, but it was 
disregarded in every classification test. 
After that, a two-stage classification strategy was devised in order to classify 
patients according to their resistance profile. Figure 3.6.1 is an illustration of how it 
works. 
For the first step, the filtered classification, a two class classification strategy was 
employed, where all the instances belonging to clusters of resistant profiles were 
grouped into a single class (R), whereas patients without any resistance were grouped 
into another class (NR). The filtered classification was always done with a SMOTE 
filter with a percentage of SMOTE instances to create of 500% and the classification 
algorithms tested were Decision Tables and Random Forests with a 10-fold cross-
validation. 
 
17 
 
 
Figure 3.6.1: Two-stage classification strategy architecture 
 
Next, the instances that were classified as Resistant, had their "original" profile 
classifications reassigned, meaning, the ones that were predicted by the expectation-
maximization algorithm. Hence the importance of having an ID, so that the predicted 
instances can be traced back to the original input file so that their cluster can be 
retrieved. Instances classified as Non-resistant, were removed from the dataset. 
Afterwards, those same instances were classified via Multiclass Classification, so 
that the multi-class dataset could be handled with 2-class classifiers. The classification 
algorithms used were again Decision Tables and Random Forests, always with 10-fold 
cross-validation, and the methods used for transforming the multi-class problem into 
several 2-class ones were 1-against-all and 1-against-1. 
The difference between these two methods is that, while 1-against-all takes one 
class and tests it against all the remaining ones, 1-against-1 does the same, but only 
against one at a time, repeating the procedure until all the possibilities have been 
covered. 
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Finally, the precision, recall and F-measure were compiled so that the different 
algorithm tests could be compared. The following formulas illustrate how each of these 
metrics is calculated: 
 
      
 
 
The tp refers to true positives, whereas the fp refers to false positives and fn to 
false negatives. Establishing a connection between these terms and our problem we 
would have: 
 
 True positive - number of correct classifications from positive examples 
 True negative - number of correct classifications from negative examples 
 False positive - number of incorrect classifications from positive examples 
 False negative - number of incorrect classifications from negative 
examples 
 
Another approach tested was based on a direct classification of instances into 
resistance profiles, correcting some of the erroneous cluster assignments made by the 
clustering algorithm. Instances wrongly assigned to a cluster were reassigned. A new 
cluster named "cluster 9" was created for the cases in which an instance did not fit in 
any of the already existing clusters (for instance, if the patient only showed resistance to 
SXT). Then, the entire process described in Figure 3.2 was repeated using this new data 
set. 
Finally, yet another approach was tested, one that, besides the information used in 
the previous ones, included a newly created compound feature: the number of instances 
belonging to each cluster in the current month. The same tests as before were performed 
using this dataset with the month values information. 
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3.7  Time Series 
After all the classification tests were done, both by antibiotic and resistance 
profile, a new dataset was devised, where each instance represented a month and whose 
features relate to the number of patients that belonged to cluster on the corresponding 
month, so that time series analysis and forecasting could be performed over it. This 
would allow to make predictions of the evolution of the number of patients belonging to 
a certain antibiotic resistance profile. 
The algorithms used for the base learner were Decision Tables and Random 
Forests, due to their previous usage in the project and time constraints. The tests were 
evaluated on training, the periodicity was left unknown, and the predictions were made 
one-step-ahead. 
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Chapter 4 
Results 
In this section, the results of the cleaning and normalization tasks, as well as the 
classification tests will be presented. 
 
4.1  Data Normalization and Transformation 
As it was previously mentioned in sections 3.2 and 3.3, after receiving the data set 
that would support the work, I proceeded to analyze it and perform data cleaning and 
normalization. After the deletion of the entries that had vital information missing, some 
data features were normalized to cope with their heterogeneous labels. 
Table 4.1.1 shows a few examples of entries that were normalized, and the 
changes that resulted from it. 
 
Feature Original entries Normalized entries 
Hospital name 
"HVFXira" 
"HVFXira" 
"HFXira" 
"HCUF" 
"CUF" 
"CUF" 
Origin of the test fluid 
"LIQ. ?" 
"Liq." "Liq?" 
"Liq." 
"NAS" 
"Nasal" 
"Nasal" 
 
Table 4.1.1: Data normalization examples 
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Afterwards, some features were transformed in order to group them by expert 
categories. Some examples that illustrate the changes that derived from the data 
transformation can be seen in Table 4.1.2. 
 
Feature Description Original entries Transformed entries 
Location 
The hospitals were grouped by 
their NUTS II region 
INSA 
Lisbon ("Lisboa") 
HSM 
INSP 
North ("Norte") 
HVNG 
Date 
The entries' season was derived 
from their date 
31/05/1995 
Spring ("Primavera") 
16/06/1995 
26/06/1995 
Summer ("Verão") 
28/06/1995 
Origin of the 
test fluid 
Grouped into categories by 
probable infection type 
Bronchial 
secretion 
("Secreção 
Brônquica") 
Lower respiratory 
tract ("Respiratória 
Inferior") Bronchial lavage 
("Lavado 
Brônquico") 
Nasal ("Nasal") Upper respiratory 
tract ("Respiratória 
Superior") 
Nasopharyngeal 
("Nasofaringeal") 
Patient age 
Grouped into several age 
categories (children vs. adults 
and year slots) 
1 
"C" and "1-2A" 
2 
18 
"A" and "18-50A" 
33 
Antibiotic test 
results 
The entries were split into 
Resistant or Non-Resistant 
according to the colours their 
numeric values showed 
Blue values Resistant 
("Resistente") Yellow values 
Red values 
Non-Resistant ("Não 
Resistente") 
 
Table 4.1.2: Data transformation examples 
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4.2  Statistical Analysis 
To have a better perception of the dataset that supported this project, a thorough 
statistical analysis was made. 
First of all, it was important to know how many blank entries were found in each 
of the relevant features of the dataset (see Table 4.2.1). 
 
 
Number of blank entries in each relevant feature 
Feature Number of blank entries 
Inpatient or ambulatory patient 1997 (52.57%) 
Laboratory name 0 (0%) 
Analysis date 28 (0.73%) 
Origin of the test fluid 110 (2.88%) 
Category of the type of infection 110 (2.88%) 
Serotype 2025 (53.11%) 
Patient age 582 (15.26%) 
Patient gender 1282 (33.62%) 
Patient's first diagnosis 3582 (93.94%) 
Antibiotics test results 0 (0%) 
 
Table 4.2.1: Number of blank entries in each relevant feature 
 
 
A first analysis clearly showed that the patient's first diagnosis, having over 90% 
of its entries blank, is not a suitable feature to work with and was consequently 
discarded. Other features, such as whether the patient was an in-patient or if he was only 
attending a doctor's appointment or the serotype showed about half blank entries. 
Although a significant number, they could still be proven useful and were therefore kept 
for the classification. 
Although the dataset has patients from 6 different regions, over 90% of these are 
from either Lisbon or the North. This means that it will be hard to draw any conclusions 
regarding any of the remaining 4 regions (Alentejo, Algarve, Madeira and Center). 
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The entries are evenly distributed throughout all the years from 1994 to 2004. 
There are less entries from 1993 and 2005, since these are the border years of the 
dataset. The same goes for months and seasons, which is very good, as it shows that the 
dataset is continuous and may allow to examine if there are interesting patterns by 
season, or if there were any antibiotic resistance peaks and try to infer why, for 
example. 
Around two thirds of the patients were adults and around the same percentage 
were male. Figure 4.2.1 illustrates how many patients showed resistance to each 
antibiotic, out of all the 3813 entries: 
 
 
 
Figure 4.2.1: Resistant patients by antibiotic 
 
 
At a first glance, there data seems to have a class imbalance problem for all 
antibiotics, since the number of patients that show resistance to any of them is a lot 
smaller that the number of patients that do not. 
 
4.3  Classification by Antibiotic 
In the individual antibiotic classification task, Decision Tables, Random Forests, 
Support Vector Machines and Multilayer Perceptron were applied without any filters. 
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Table 4.3.1 shows the precision, recall and F-measure results for the tests using 
Decision Tables with a 10-fold cross-validation for every antibiotic. 
 
 
Antibiotic Filter 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
SXT None 0 0 0 0.987 1 0.994 
OXA None 0 0 0 0.984 1 0.992 
MIC Penic None 0.571 0.066 0.118 0.97 0.998 0.984 
Tetra None 0.605 0.364 0.455 0.895 0.958 0.926 
Eritr None 0.609 0.198 0.299 0.892 0.981 0.934 
Clinda None 0.598 0.188 0.286 0.922 0.987 0.953 
Cloranf None 0.476 0.522 0.498 0.969 0.963 0.966 
Oflox None 0 0 0 0.996 1 0.998 
Cefotx None 0 0 0 0.983 1 0.991 
Ceftriax None 0 0 0 0.994 1 0.997 
 
Table 4.3.1: Classification by antibiotic results using Decision Tables 
 
The results using Random Forests, Support Vector Machines and Multilayer 
Perceptron with a 10-fold cross-validation for Tetramycin, seeing as it was one 
antibiotics with best results in the table above, can be seen on Table 4.3.2. 
 
 
Antibiotic Algorithm 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
Tetra 
Random 
Forests 
0.800 0.056 0.105 0.857 0.998 0.992 
Tetra SVM 0 0 0 0.850 1 0.919 
Tetra 
Multilayer 
Perceptron 
0.492 0.382 0.430 0.895 0.931 0.913 
 
Table 4.3.2: Classification results for Tetramycin using other algorithms 
 
From these results it was obvious the there was a class imbalance problem, due to 
the number of non-resistant patients being much higher than the number of resistant 
ones. This lead to most of the already few resistant patients being classified as non-
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resistant. Hence the very high accuracy regarding the non-resistant patients, and the 
opposite regarding those that showed resistance. 
In order to counter this class imbalance problem, two different filters were used 
with filtered classifying: SMOTE at 200% (see Tables 4.3.3 and 4.3.4) and Spread 
Subsample with a uniform distribution (see Tables 4.3.5 and 4.3.6). 
 
 
SMOTE (with a percentage of 200) 
 
Antibiotic Filter 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
SXT SMOTE 0.286 0.042 0.073 0.988 0.999 0.993 
OXA SMOTE 0.007 0.016 0.01 0.983 0.965 0.974 
MIC Penic SMOTE 0.364 0.066 0.111 0.97 0.996 0.983 
Tetra SMOTE 0.582 0.431 0.495 0.904 0.945 0.924 
Eritr SMOTE 0.457 0.304 0.365 0.901 0.946 0.923 
Clinda SMOTE 0.424 0.21 0.281 0.922 0.97 0.946 
Cloranf SMOTE 0.333 0.543 0.413 0.969 0.93 0.949 
Oflox SMOTE 0 0 0 0.996 0.999 0.998 
Cefotx SMOTE 0.467 0.108 0.175 0.985 0.998 0.991 
Ceftriax SMOTE 0.071 0.043 0.054 0.994 0.997 0.995 
 
Table 4.3.3: Classification by antibiotic results using Decision Tables with a SMOTE filter 
(200%) 
 
 
 
Antibiotic Algorithm 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
Tetra Random Forests 0.650 0.068 0.124 0.858 0.994 0.921 
Tetra SVM 0.366 0.112 0.172 0.861 0.966 0.919 
Tetra 
Multilayer 
Perceptron 
0.504 0.419 0.457 0.901 0.928 0.914 
 
Table 4.3.4: Classification results for Tetramycin using other algorithms with a SMOTE 
filter (200%) 
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Spread Subsample (with a distribution spread of 1) 
 
Antibiotic Filter 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
SXT Spread Subsample 0.027 0.958 0.053 0.999 0.564 0.721 
OXA Spread Subsample 0.035 0.871 0.067 0.996 0.6 0.749 
MIC Penic Spread Subsample 0.154 0.828 0.26 0.993 0.85 0.916 
Tetra Spread Subsample 0.466 0.536 0.499 0.916 0.892 0.904 
Eritr Spread Subsample 0.289 0.516 0.371 0.918 0.811 0.861 
Clinda Spread Subsample 0.152 0.641 0.246 0.945 0.631 0.757 
Cloranf Spread Subsample 0.214 0.737 0.332 0.98 0.825 0.896 
Oflox Spread Subsample 0.005 0.714 0.01 0.998 0.491 0.658 
Cefotx Spread Subsample 0.081 0.892 0.149 0.998 0.826 0.903 
Ceftriax Spread Subsample 0.014 0.696 0.027 0.997 0.701 0.823 
 
Table 4.3.5: Classification by antibiotic results using Decision Tables with a Spread 
Subsample filter 
 
 
Antibiotic Algorithm 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
Tetra Random Forests 0.235 0.445 0.307 0.884 0.744 0.808 
Tetra SVM 0.223 0.518 0.312 0.889 0.682 0.772 
Tetra 
Multilayer 
Perceptron 
0.265 0.660 0.378 0.919 0.677 0.780 
 
Table 4.3.6: Classification results for Tetramycin using other algorithms with a Spread 
Subsample filter 
 
The results show that the SMOTE filter brought some improvements, but not 
enough to be considered a valid option. As for the Spread Subsample filter, the recall 
raised significantly, but at the expense of a great reduction on the precision in most 
cases. 
Since some improvements were verified when testing with a SMOTE filter with a 
percentage of SMOTE instances of 200, another test was made with a higher percentage 
(500%). On average this improved the F-measure but overall performance was still very 
low (see Tables 4.3.7 and 4.3.8). 
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SMOTE (with a percentage of 500) 
 
Antibiotic Filter 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
SXT SMOTE 0 0 0 0.987 0.999 0.993 
OXA SMOTE 0 0 0 0.984 0.992 0.988 
MIC Penic SMOTE 0.417 0.041 0.075 0.969 0.998 0.983 
Tetra SMOTE 0.541 0.506 0.523 0.914 0.924 0.919 
Eritr SMOTE 0.432 0.109 0.174 0.881 0.979 0.927 
Clinda SMOTE 0.156 0.014 0.026 0.907 0.992 0.948 
Cloranf SMOTE 0.247 0.522 0.335 0.967 0.897 0.930 
Oflox SMOTE 0 0 0 0.996 1 0.998 
Cefotx SMOTE 0.462 0.092 0.154 0.984 0.998 0.991 
Ceftriax SMOTE 0 0 0 0.994 0.998 0.996 
 
Table 4.3.7: Classification by antibiotic results using Decision Tables with a SMOTE filter 
(500%) 
 
 
Antibiotic Algorithm 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
Tetra Random Forests 0.505 0.082 0.142 0.859 0.986 0.918 
Tetra SVM 0.262 0.356 0.302 0.879 0.824 0.851 
Tetra 
Multilayer 
Perceptron 
0.484 0.420 0.450 0.900 0.921 0.911 
 
Table 4.3.8: Classification results for Tetramycin using other algorithms with a SMOTE 
filter (500%) 
 
Due to the low performance of the tests made until then, an Information Gain 
Attribute Evaluation was performed to find the most relevant features. These were the 6 
most relevant ones: 
 
 Region where the analysis was made 
 Month 
 Category of the type of infection 
 Serotype 
 Patient age 
 Whether the patient was a child or an adult 
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The same four algorithms and filters as before were tested over this new dataset 
with less features. The SMOTE filter was performed with a percentage of 500%, due to 
the slightly better results compared with the ones with a percentage of 200% on the 
previous tests. The results obtained for Tetramycin are shown in Table 4.3.9. 
 
Algorithm Filter 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
Decision 
Tables 
None 0.611 0.361 0.454 0.895 0.960 0.926 
SMOTE 0.512 0.506 0.509 0.913 0.915 0.914 
Spread Subsample 0.466 0.536 0.499 0.916 0.892 0.904 
Random 
Forests 
None 0.694 0.075 0.136 0.859 0.994 0.922 
SMOTE 0.305 0.159 0.209 0.863 0.936 0.898 
Spread Subsample 0.228 0.455 0.304 0.884 0.728 0.798 
SVM 
None 0 0 0 0.850 1 0.919 
SMOTE 0.330 0.306 0.318 0.879 0.890 0.885 
Spread Subsample 0.226 0.494 0.310 0.887 0.702 0.784 
Multilayer 
Perceptron 
None 0.501 0.320 0.391 0.887 0.944 0.915 
SMOTE 0.471 0.401 0.433 0.897 0.921 0.909 
Spread Subsample 0.233 0.646 0.342 0.909 0.625 0.741 
 
Table 4.3.9: Classification results for Tetramycin using feature selection 
 
As it was mentioned in the previous section, some antibiotics were also grouped 
by similarity in antibiotic families. These families were also tested the same way the 
antibiotics were. Table 4.3.10 shows the results for each antibiotic tested with Decision 
Tables without any filter applied and with the same filters as before. 
 
Antibiotic 
Family 
Filter 
Resistant Non-resistant 
Precision Recall F-Measure Precision Recall F-Measure 
OXA + MIC 
Penic 
None 0 0 0 0.952 1 0.975 
SMOTE 0.069 0.23 0.106 0.956 0.845 0.897 
Spread Subsample 0.129 0.82 0.222 0.988 0.72 0.833 
Eritr + 
Clinda 
None 0.618 0.19 0.29 0.89 0.983 0.934 
SMOTE 0.461 0.3 0.364 0.901 0.948 0.923 
Spread Subsample 0.225 0.69 0.332 0.924 0.677 0.781 
Cefotx + 
Ceftriax 
None 0 0 0 0.983 1 0.991 
SMOTE 0.267 0.061 0.099 0.984 0.997 0.99 
Spread Subsample 0.095 0.894 0.172 0.998 0.85 0.918 
 
Table 4.3.10: Classification results for antibiotic families using Decision Tables 
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The results were very similar to the ones when the antibiotics were tested 
separately. 
4.4  Antibiotic Resistance Profiling 
In an attempt to overcome the low performance observed in classification by 
individual antibiotic resistance or family, a new strategy was devised based on a three 
step approach:  
 
1. Instances were clustered into resistance profiles; 
2. Instances were classified as resistant (resistant to at least one antibiotic) 
and non-resistant (to all); 
3. Resistant classified instances were re-classified in a multiclass approach to 
the resistance profiles. 
 
The instances were divided in 9 different clusters. Their profiles and how many 
instances were clustered into each one of them can be consulted in Table 4.4.1 and 
Figure 4.4.1, respectively. 
 
Cluster Resistant to 
Cluster 0 None 
Cluster 1 
Tetramycin, Erythromycin, Clindamycin and 
Chloramphenicol 
Cluster 2 Erythromycin 
Cluster 3 Erythromycin and Clindamycin 
Cluster 4 
Penicillin, Tetramycin, Clindamycin and 
Cefotaxime 
Cluster 5 OXA 
Cluster 6 Tetramycin, Erythromycin and Clindamycin 
Cluster 7 Tetramycin and Chloramphenicol 
Cluster 8 Penicillin and Cefotaxime 
 
Table 4.4.1: Relation between clusters and resistance profiles 
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Figure 4.4.1: Clustered instances by cluster 
 
4.5  Classification by Profile Resistance 
After these clusters were made, the two-stage classification strategy previously 
described in section 3.6 was tested. Given the algorithm performances for the 
classification by antibiotic (section 4.3), Support Vector Machines and Multilayer 
Perceptron were discarded. The first due to its unsatisfying results, and the second 
because of computational power and time constraints. For the filtered classification step, 
a SMOTE filter with a percentage of 500% was used. 
Table 4.5.1 shows the results for the filtered classification step of the two-stage 
classification strategy. 
 
Algorithm 
Cluster 0 Cluster 1 
Precision Recall F-Measure Precision Recall F-Measure 
Decision Table 0.897 0.888 0.892 0.503 0.526 0.514 
Random Forest 0.835 0.977 0.901 0.5 0.106 0.175 
 
Table 4.5.1: Classification results for the first step of the two-stage classification strategy 
without cluster adjustment 
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Then, after the instances predicted into Cluster 1 were give their original clusters 
back, they were classified with multiclass classification (1-against-all and 1-against-1), 
using the same algorithms that were used in the filtered classification. The results for 
the multiclass classification with Random Forests after the filtered classification with 
Decision Tables, seeing as it was the algorithm with the best results, can be consulted in 
Table 4.5.2. 
 
 
Cluster 
1-against-all 1-against-1 
Precision Recall F-Measure Precision Recall F-Measure 
Cluster 0 0.595 0.786 0.677 0.588 0.839 0.691 
Cluster 1 0.1 0.024 0.038 0 0 0 
Cluster 2 0.25 0.136 0.176 0.381 0.136 0.2 
Cluster 3 0.333 0.148 0.205 0.429 0.111 0.176 
Cluster 4 0.5 0.25 0.333 0.571 0.25 0.348 
Cluster 5 0 0 0 0 0 0 
Cluster 6 0.408 0.333 0.367 0.507 0.376 0.432 
Cluster 7 0.605 0.69 0.645 0.609 0.67 0.638 
Cluster 8 0 0 0 0 0 0 
 
Table 4.5.2: Classification results for the second step of the two-stage classification strategy 
without cluster adjustment 
 
The outcomes of the tests with each of the other algorithms were similar. 
 
Next, classification by resistance profile was tested again, only this time 
discarding the prediction errors when grouping the instances into clusters, as it was 
explained in the previous section. Figure 4.5.1 shows the number of clustered instances 
in each cluster after this cluster adjustment. The results for the filtered classification step 
using the new dataset are shown in Table 4.5.3. 
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Figure 4.5.1: Clustered instances by cluster after cluster adjustment 
 
 
 
Algorithm 
Cluster 0 Cluster 1 
Precision Recall F-Measure Precision Recall F-Measure 
Decision Table 0.864 0.854 0.859 0.538 0.56 0.549 
Random Forest 0.784 0.958 0.862 0.485 0.131 0.207 
 
Table 4.5.3: Classification results for the first step of the two-stage classification strategy 
with cluster adjustment 
 
 
The results for the patients resistant to any antibiotic (Cluster 1) improved slightly 
when compared to the previous approach, where the clustering prediction errors were 
not corrected. 
As for the multiclass classification, the Random Forest showed better results than 
those from the Decision Tables (see Table 4.5.4). 
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Cluster 
1-against-all 1-against-1 
Precision Recall F-Measure Precision Recall F-Measure 
Cluster 0 0.577 0.769 0.659 0.572 0.809 0.67 
Cluster 1 0.25 0.061 0.098 0.25 0.03 0.054 
Cluster 2 0.333 0.167 0.222 0.583 0.167 0.259 
Cluster 3 0.375 0.125 0.188 0.75 0.125 0.214 
Cluster 4 0 0 0 0 0 0 
Cluster 5 0.2 0.095 0.129 0.25 0.095 0.138 
Cluster 6 0.344 0.239 0.282 0.4 0.196 0.263 
Cluster 7 0.481 0.5 0.491 0.481 0.474 0.477 
Cluster 8 0.3 0.176 0.222 0.375 0.176 0.24 
Cluster 9 0.333 0.279 0.304 0.348 0.313 0.329 
 
Table 4.5.4: Classification results for the second step of the two-stage classification strategy 
with cluster adjustment 
 
 
As it was mentioned at the end of section 3.6, more classification tests were made 
using the two-stage classification strategy over a dataset with the number of patients 
belonging to each cluster per month. The results for the filtered classification step using 
the new dataset with Decision Tables and Random Forests with a SMOTE filter with a 
percentage of 500%, as usual, are shown in Table 4.5.5. 
 
 
Algorithm 
Cluster 0 Cluster 1 
Precision Recall F-Measure Precision Recall F-Measure 
Decision Table 0.864 0.854 0.859 0.538 0.56 0.549 
Random Forest 0.784 0.958 0.862 0.485 0.131 0.207 
 
Table 4.5.5: Classification results for the first step of the two-stage classification strategy 
with month values 
 
 
Once again, Decision Tables obtained better results on the filtered classification 
step, and Random Forests on the multiclass classification one (see Table 4.5.6) 
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Cluster 
1-against-all 1-against-1 
Precision Recall F-Measure Precision Recall F-Measure 
Cluster 0 0.576 0.781 0.663 0.576 0.809 0.673 
Cluster 1 0 0 0 0 0 0 
Cluster 2 0.5 0.167 0.25 0.636 0.167 0.264 
Cluster 3 0.3 0.125 0.176 0.6 0.125 0.264 
Cluster 4 0.143 0.111 0.125 0 0 0 
Cluster 5 0.25 0.095 0.138 0.222 0.095 0.133 
Cluster 6 0.469 0.326 0.385 0.453 0.261 0.331 
Cluster 7 0.605 0.59 0.597 0.62 0.564 0.591 
Cluster 8 0.571 0.471 0.516 0.571 0.471 0.516 
Cluster 9 0.379 0.317 0.346 0.374 0.327 0.349 
 
Table 4.5.6: Classification results for the second step of the two-stage classification strategy 
with month values 
 
The results show a clear improvement overall when compared to the previous two 
approaches, albeit not achieving the maximum 0.645 F-measure result for any cluster, 
as it was verified on the first test made for classification by profile resistance. 
 
4.6  Time Series 
Based on the results obtained from the classification from profile resistance, the 
first forecasting tests were made over cluster 7, since it was the one that obtained the 
best prediction results. 
Figure 4.6.1 shows a comparison between the one-step-ahead predictions (in blue) 
and the actual values of cluster 7 (in red) using a Random Forest algorithm as the base 
learner. The mean absolute error calculated for the prediction was 0.2733, whereas 
using Decision Tables it would be 0.3516. It is clear that the Random Forest algorithm 
was able to predict every resistance peak. 
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Figure 4.6.1: One-step-ahead predictions for cluster 7 
 
 
The prediction results were satisfying. Figure 4.6.2 shows the future forecast for 
the evolution of the number of patients fitting in cluster 7 (resistant to Tetramycin and 
Chloramphenicol) over the next 24 months. 
 
 
Figure 4.6.2: Future forecast for cluster 7 
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However, as it was seen in Figure 4.5.1, only 2.44% of the total instances in the 
dataset were clustered to cluster 7. Therefore, I felt there was a need to make a 
prediction for a cluster that had more representation on the dataset. As a result, the same 
tests were made for cluster 9, the one that had the most instances (9.13%), disregarding 
cluster 0, since it represents patients that are not resistant to any antibiotic. 
In this test, the Decision Table algorithm showed a very low mean absolute error 
of 0.0376, while the Random Forest one had 0.591. As it can be seen in Figure 4.6.3, 
the predictions for cluster 9 using Decision Tables as base learner overlap the actual 
values in almost every month (and are thus obscured in the graph). 
 
 
 
Figure 4.6.3: One-step-ahead predictions for cluster 9 
 
 
The future forecast, on the other hand, assumes a bizarre constancy tendency, as 
Figure 4.6.4 demonstrates. This constancy tendency was present in every future forecast 
made with Decision Tables, regardless of the cluster. 
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Figure 4.6.4: Future forecast for cluster 9 
 
Finally, Table 4.6.1 shows the mean absolute error values for one-step-ahead 
prediction for each cluster using Decision Tables and Random Forests as base learners 
for the forecast. 
 
Cluster Decision Tables Random Forests 
Cluster 0 6.4954 2.8791 
Cluster 1 0.3546 0.1811 
Cluster 2 0.2612 0.27 
Cluster 3 0.1075 0.2037 
Cluster 4 0.0345 0.0371 
Cluster 5 0.1387 0.095 
Cluster 6 1.0694 0.4688 
Cluster 7 0.3516 0.2733 
Cluster 8 0.1071 0.0776 
Cluster 9 0.0376 0.591 
 
Table 4.6.1: mean absolute error values for one-step-ahead predictions 
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Chapter 5 
Discussion 
Although several different approaches to the problem were made, the results show 
that with the data set that was provided it was not possible to develop a high-performing 
classification model for patient-based antibiotic resistance. However, the results show 
that there is a clear relationship between the number of instances in each class and their 
classification performance. For every test that was made, whether it was testing 
classification by antibiotic or by profile resistance, the precision, recall and F-measure 
results were always much better in classes that represented non-resistant patients. In 
section 4.1, the statistical analysis demonstrated how for every antibiotic the number of 
non-resistant patients greatly exceeded the number of resistant ones. Class imbalance 
strategies such as SMOTE and Spread Subsample were ineffective in mitigating this 
issue. However, for the profile ‘Tetramycin and Chloramphenicol’ the two-stage 
classification strategy was able to produce a 0.645 F-measure, a significantly higher 
value than that obtained for the other resistance profiles. 
Understanding that the initial problem formulation (one class for each antibiotic) 
was not the best way to tackle the problem was very important. By using clustering, the 
classification problem was reformulated, which lead to some performance 
improvements. 
 Besides the issues with class imbalance, there were several other difficulties that 
may have contributed to the failure of the classification approaches. One very relevant 
aspect was the missing data. The first diagnosis feature from the original data set had 
over 93% of blank entries. The first diagnosis could give valuable information regarding 
the patient's condition upon arrival to the hospital, or some pathology that was 
diagnosed. It is not possible to know to which extent this could possibly alter the results, 
but this could have been an extremely important source of information. The high 
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number of blank entries (over 50%) on the serotype feature was also a negative point 
from the data set. Determining the serotype takes much less time than resistance 
experiments. If the reported data had more information regarding the serotype, it could 
have potentially improved the predictions. The same goes for the feature that indicated 
whether the patient was an in-patient or if he was only attending an appointment, where 
over 50% of the instances were blank. Since the type of bacteria in nosocomial 
infections is different from community acquired ones, it could have been important to 
have this information. 
 The heterogeneity in labels and in filling in data may have also played a role. 
Even though this is understandable, since the data was collected by different staff in 
different points of the country, it lead to the loss of some potentially valuable 
information. For instance, many entries did not stated the patient's age, only whether 
he/she was a child or an adult. 
Finally, the geographical normalization of data may also be at fault. The NUTS II 
regions, although commonly used in public health statistics, do not capture geographic 
proximity in border regions. Moreover, patient's address may differ substantially from 
the hospital where they were admitted, especially in larger regions. The classification of 
sample sources according to expert categories may also introduce noise. 
In 2005, Pechenizkiy et al. [2] achieved good results on antibiotic resistance 
prediction for nosocomial infections (84.5%). However, their dataset had more data 
related to the hospitalization, like the number of days of stay in the ICU, if the bacteria 
was isolated while the patient was in the ICU or the department of stay, and it only 
contained data collected from one hospital, meaning they had no problems with 
heterogeneous labels. 
Their analysis was based upon 4430 instances of sensitivity tests related to 
meningitis cases. Our dataset was much more heterogeneous in that it covered different 
hospitals, all types of bacterial infections, both nosocomial and community acquired 
infections and all kinds of biological samples, and had virtually no diagnosis data. The 
most similar instances in the dataset used for this project were the ones where the test 
fluid was cerebrospinal fluid. The two-stage classification strategy described in section 
3.6 was tested using only these instances, but without the same success as theirs (see 
Appendix II).  
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These lower results can be explained by the high discrepancy in the number of 
instances used for the tests (4430 vs 307) and by the fact that they were working with a 
single bacteria and a single diagnostic, a much less complex problem that the one 
developed here. 
In spite of not being able to develop the aforementioned supervised learning 
models with the data set that was provided, there was some success in finding the 
resistance profiles for the patients and in applying this strategy to one of the resistance 
profiles.  
Time series forecasting was also performed over these successfully found 
resistance profiles, to predict the future evolution of the number of patients belonging to 
each profile. Although one-step-ahead prediction performed well, the 24 month 
forecasting results were not as satisfying, especially when using Decision Tables. 
Further studies would need to be conducted in order to elucidate the reasons behind this. 
I believe that with more instances, with better quality and a few more informative 
attributes (such as those used in Pechenizky et al.), the profile resistance classification 
approach can be applied with more success to such a complex problem as predicting 
antibiotic resistance risk.  
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Chapter 6 
Conclusions 
This project's goal was to investigate if it was possible to develop supervised 
learning models that could classify patients regarding their antibiotic resistance risk 
using the information that is usually reported at a clinical and laboratorial level in what 
regards antibiotic resistance.  
Antibiotic resistance is a real problem, and one of WHO's main concerns 
nowadays [4]. Developing a model that could successfully predict antibiotic resistance 
risk could have a significant impact worldwide, since it could help clinicians in 
selecting appropriate antibiotics, resulting in a reduction of the antibiotic resistance 
levels, an improvement of patient treatment, and ultimately decreasing healthcare costs. 
The data cleaning and normalization process was successful. Instances with 
important missing data were removed and some features that contained heterogeneous 
labels were normalized, making the dataset more consistent. 
However, the first approach, where classification by antibiotic was tested, proved 
unsuccessful. This led to a different problem formulation, where classification would be 
performed by profile resistance instead. The first step was to group the instances 
according to the patients antibiotic resistance profiles via clustering. This antibiotic 
resistance profiling was successfully accomplished. Then, a two-stage classification 
approach was employed, where in the first step instances were classified into Resistant 
and Non-resistant, regardless of antibiotic, and then Resistant classified instances were 
re-classified into resistance profiles. Even though the profile classification results had a 
low performance in general, it proved to be somewhat successful for the profile 
‘Tetramycin and Chloramphenicol’ at 0.645 F-measure, which may indicate that with 
better data this strategy may be successfully applied to antibiotic resistance risk 
prediction.  
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This work highlighted two important issues: ensuring the quality and 
representativeness of the collected data is crucial, as the reported information did not 
provide enough predictive power to learn a classification model to predict antibiotic 
resistance risk; and also, that a good understanding of the domain is necessary, since a 
reformulation of the problem from predicting individual resistance to profile resistance 
was shown to improve some of the results. 
Considering that the data collected spanned a period until 10 years ago, it is 
expectable that with the recent evolutions in the Health Information Systems employed 
by Portuguese hospitals, a collection of more recent data would provide better quality 
data. It would be interesting to apply the proposed strategy to more recent data, and test 
if it would indeed improve the classification performance. 
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Appendices 
Appendix I: Parameters used for each classification algorithm  
 
 
Algorithm Parameters 
Decision Tables 
weka.classifiers.rules.DecisionTable -X 1 -S 
"weka.attributeSelection.BestFirst -D 1 -N 5" 
Random Forests 
weka.classifiers.trees.RandomForest -I 100 -K 0 -S 
1 -num-slots 1 
Support Vector Machines 
weka.classifiers.functions.LibSVM -S 0 -K 2 -D 3 -
G 0.0 -R 0.0 -N 0.5 -M 40.0 -C 1.0 -E 0.001 -P 0.1 
-model C:\Stuff\Weka-3-7 -seed 1 
Multilayer Perceptron 
weka.classifiers.functions.MultilayerPerceptron -L 
0.3 -M 0.2 -N 500 -V 0 -S 0 -E 20 -H a 
 
Table A.I.1: Parameters used for each algorithm 
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Appendix II: Classification by profile resistance results for 
patients whose test fluid was cerebrospinal fluid  
 
 
 
Algorithm 
Cluster 0 Cluster 1 
Precision Recall F-Measure Precision Recall F-Measure 
Decision Table 0.93 0.802 0.861 0.473 0.746 0.579 
Random Forest 0.882 0.935 0.908 0.636 0.475 0.544 
 
Table A.II.1: Filtered Classification results using a 500% SMOTE filter for patients whose test 
fluid was cerebrospinal fluid 
 
 
 
Cluster 
1-against-all 1-against-1 
Precision Recall F-Measure Precision Recall F-Measure 
Cluster 0 0.508 0.825 0.629 0.47 0.775 0.585 
Cluster 1 0 0 0 0 0 0 
Cluster 2 0 0 0 0 0 0 
Cluster 3 0.75 0.429 0.545 0.4 0.286 0.333 
Cluster 4 0 0 0 0 0 0 
Cluster 5 0.25 0.25 0.25 0 0 0 
Cluster 6 0 0 0 0 0 0 
Cluster 7 0 0 0 0 0 0 
Cluster 8 0 0 0 0 0 0 
Cluster 9 0.333 0.188 0.24 0.25 0.125 0.167 
 
Table A.II.2: Multiclass Classification results for patients whose test fluid was cerebrospinal fluid 
using Decision Tables after using Decision Tables for the Filtered Classification 
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Cluster 
1-against-all 1-against-1 
Precision Recall F-Measure Precision Recall F-Measure 
Cluster 0 0 0 0 0 0 0 
Cluster 1 0 0 0 0 0 0 
Cluster 2 1 0.333 0.5 0 0 0 
Cluster 3 0.714 0.714 0.714 0.714 0.714 0.714 
Cluster 4 0 0 0 0 0 0 
Cluster 5 0.833 1 0.909 1 0.4 0.571 
Cluster 6 0.846 0.733 0.786 0.813 0.867 0.839 
Cluster 7 0 0 0 0 0 0 
Cluster 8 0 0 0 0 0 0 
Cluster 9 0.759 1 0.863 0.656 0.955 0.778 
 
Table A.II.3: Multiclass Classification results for patients whose test fluid was cerebrospinal fluid 
using Random Forests after using Random Forests for the Filtered Classification 
 
 
Cluster 
1-against-all 1-against-1 
Precision Recall F-Measure Precision Recall F-Measure 
Cluster 0 0.561 0.8 0.66 0.508 0.825 0.629 
Cluster 1 0 0 0 0 0 0 
Cluster 2 0 0 0 0 0 0 
Cluster 3 0.75 0.429 0.545 0.75 0.429 0.545 
Cluster 4 0 0 0 0 0 0 
Cluster 5 0.4 0.5 0.444 0 0 0 
Cluster 6 0 0 0 0 0 0 
Cluster 7 0 0 0 0 0 0 
Cluster 8 0 0 0 0 0 0 
Cluster 9 0.533 0.5 0.516 0.444 0.25 0.32 
 
Table A.II.3: Multiclass Classification results for patients whose test fluid was cerebrospinal fluid 
using Random Forests after using Decision Tables for the Filtered Classification 
 
 
 
 
 
